Light Sciences Oncology Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Out of Business

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Out of Business

Light Sciences Oncology General Information

Description

Developer of a water-soluble drug designed to treat solid tumors. The company's Talaporfin Sodium drug is a water-soluble drug targeted by a small, single-use and disposable drug activator, enabling patients to get repeatable and non-invasive treatment treatments.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 12600 South East 38th Street
  • Suite 111
  • Bellevue, WA 98006
  • United States
+1 (425)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 12600 South East 38th Street
  • Suite 111
  • Bellevue, WA 98006
  • United States
+1 (425)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Light Sciences Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Jul-2019 Completed Out of Business
9. Later Stage VC 10-Jan-2019 Completed Generating Revenue
8. Later Stage VC 20-Dec-2013 Completed Generating Revenue
7. Later Stage VC 23-Jan-2012 Completed Generating Revenue
6. Grant 02-Nov-2010 Completed Generating Revenue
5. Later Stage VC (Series C) 16-Jul-2008 Completed Generating Revenue
4. IPO 07-Feb-2008 Cancelled Generating Revenue
3. Debt - General 31-Dec-2007 Completed Generating Revenue
2. Later Stage VC (Series B) 11-Jul-2007 $30M $100M Completed Generating Revenue
1. Later Stage VC (Series A) 14-Dec-2005 $70M $70M Completed Generating Revenue
To view Light Sciences Oncology’s complete valuation and funding history, request access »

Light Sciences Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 13,429,989 $0.4 $5 $5 $8 17.52%
To view Light Sciences Oncology’s complete cap table history, request access »

Light Sciences Oncology Patents

Light Sciences Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2011020064-A2 Low-profile intraluminal light delivery system and methods of using the same Inactive 14-Aug-2009
WO-2011020064-A3 Low-profile intraluminal light delivery system and methods of using the same Inactive 14-Aug-2009
US-20110008372-A1 Enhancement of light activated drug therapy through combination with other therapeutic agents Inactive 08-Jul-2009
US-20100036311-A1 Enhancement of light activated therapy by immune augmentation using anti-ctla-4 antibody Active 06-Aug-2008
US-20110236402-A1 Enhancement of light activated therapy by immune augmentation using anti-ctla-4 antibody Active 06-Aug-2008 A61K41/0038
To view Light Sciences Oncology’s complete patent history, request access »

Light Sciences Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Light Sciences Oncology Acquisitions (2)

Light Sciences Oncology’s most recent deal was a Merger/Acquisition with Life Science. The deal was made on 29-Dec-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Life Science 29-Dec-2006 Merger/Acquisition Therapeutic Devices
Light Sciences 29-Dec-2006 Merger/Acquisition Drug Discovery
To view Light Sciences Oncology’s complete acquisitions history, request access »

Light Sciences Oncology FAQs

  • When was Light Sciences Oncology founded?

    Light Sciences Oncology was founded in 1994.

  • Where is Light Sciences Oncology headquartered?

    Light Sciences Oncology is headquartered in Bellevue, WA.

  • What is the size of Light Sciences Oncology?

    Light Sciences Oncology has 17 total employees.

  • What industry is Light Sciences Oncology in?

    Light Sciences Oncology’s primary industry is Drug Discovery.

  • Is Light Sciences Oncology a private or public company?

    Light Sciences Oncology is a Private company.

  • What is Light Sciences Oncology’s current revenue?

    The current revenue for Light Sciences Oncology is .

  • How much funding has Light Sciences Oncology raised over time?

    Light Sciences Oncology has raised $195M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process